These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Alleviating airway inflammation by inhibiting ERK-NF-κB signaling pathway by blocking Kv1.3 channels. Zhou QL; Wang TY; Li M; Shang YX Int Immunopharmacol; 2018 Oct; 63():110-118. PubMed ID: 30077824 [TBL] [Abstract][Full Text] [Related]
46. Cysteinyl leukotrienes in asthma: old mediators up to new tricks. Hay DW; Torphy TJ; Undem BJ Trends Pharmacol Sci; 1995 Sep; 16(9):304-9. PubMed ID: 7482995 [TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetics and pharmacodynamics of monoclonal antibodies for asthma treatment. Bagnasco D; Heffler E; Testino E; Passalacqua G; Canonica GW Expert Opin Drug Metab Toxicol; 2019 Feb; 15(2):113-120. PubMed ID: 30632416 [TBL] [Abstract][Full Text] [Related]
48. Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma. Vuolo F; Abreu SC; Michels M; Xisto DG; Blanco NG; Hallak JE; Zuardi AW; Crippa JA; Reis C; Bahl M; Pizzichinni E; Maurici R; Pizzichinni MMM; Rocco PRM; Dal-Pizzol F Eur J Pharmacol; 2019 Jan; 843():251-259. PubMed ID: 30481497 [TBL] [Abstract][Full Text] [Related]
49. Potential and novel therapies for asthma. Babu KS; Holgate ST J Assoc Physicians India; 2000 Nov; 48(11):1096-102. PubMed ID: 11310390 [TBL] [Abstract][Full Text] [Related]
50. Monoclonal antibodies for the treatment of asthma. Catley MC; Coote J; Bari M; Tomlinson KL Pharmacol Ther; 2011 Dec; 132(3):333-51. PubMed ID: 21944943 [TBL] [Abstract][Full Text] [Related]
51. Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Adcock IM; Caramori G Immunol Cell Biol; 2001 Aug; 79(4):376-84. PubMed ID: 11488985 [TBL] [Abstract][Full Text] [Related]
53. Asthma and poly(ADP-ribose) polymerase inhibition: a new therapeutic approach. Zaffini R; Gotte G; Menegazzi M Drug Des Devel Ther; 2018; 12():281-293. PubMed ID: 29483769 [TBL] [Abstract][Full Text] [Related]
54. Cytokine modulators as novel therapies for asthma. Barnes PJ Annu Rev Pharmacol Toxicol; 2002; 42():81-98. PubMed ID: 11807165 [TBL] [Abstract][Full Text] [Related]
55. Bu-Shen-Yi-Qi formulae suppress chronic airway inflammation and regulate Th17/Treg imbalance in the murine ovalbumin asthma model. Wei Y; Luo QL; Sun J; Chen MX; Liu F; Dong JC J Ethnopharmacol; 2015 Apr; 164():368-77. PubMed ID: 25625352 [TBL] [Abstract][Full Text] [Related]
56. Airway epithelial cell release of cytokines: modulation by various therapeutic agents. Frieri M Allergy Asthma Proc; 2004; 25(6):387-93. PubMed ID: 15709449 [TBL] [Abstract][Full Text] [Related]
57. Novel and emerging therapies for asthma. Leath TM; Singla M; Peters SP Drug Discov Today; 2005 Dec; 10(23-24):1647-55. PubMed ID: 16376825 [TBL] [Abstract][Full Text] [Related]
58. Anti-interleukin therapy in asthma. Dunn RM; Wechsler ME Clin Pharmacol Ther; 2015 Jan; 97(1):55-65. PubMed ID: 25670383 [TBL] [Abstract][Full Text] [Related]